Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre studyOlga Nigro, Corrado Ficorella, Pietro Di Marino et al.|European Journal of Cancer|2020Cited by 71
Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenarioGiovanni Rossi, Alessandro Russo, Aldo Pezzuto et al.|Critical Reviews in Oncology/Hematology|2019Cited by 66
EGFR T790M detection rate in lung adenocarcinomas at baseline using droplet digital PCR and validation by ultra-deep next generation sequencingLucio Lettig, Daniela Furlan, Nora Sahnane et al.|Translational Lung Cancer Research|2019Cited by 50
Biological effects of verbascoside and its anti-inflammatory activity on oral mucositis: a review of the literatureOlga Nigro, Graziella Pinotti, Alessandro Tuzi et al.|Anti-Cancer Drugs|2019Cited by 41
Biopsy and re-biopsy in lung cancer: the oncologist requests and the role of endobronchial ultrasounds transbronchial needle aspirationAlessandro Tuzi, Graziella Pinotti, Elena Bolzacchini et al.|Journal of Thoracic Disease|2017Cited by 16